The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immunotherapy Market Research Report 2025
Synopsis
The global Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immunotherapy in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immunotherapy include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapy.
Report Scope
The Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Segment by Type
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Segment by Application
Oncology
Inflammation
Central Nervous System
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immunotherapy in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immunotherapy include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapy.
Report Scope
The Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Segment by Type
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Segment by Application
Oncology
Inflammation
Central Nervous System
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Vaccines
1.2.4 Checkpoint Inhibitors
1.2.5 Non-Specific Immunotherapy
1.3 Market by Application
1.3.1 Global Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Inflammation
1.3.4 Central Nervous System
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunotherapy Market Perspective (2019-2030)
2.2 Immunotherapy Growth Trends by Region
2.2.1 Global Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 Immunotherapy Market Dynamics
2.3.1 Immunotherapy Industry Trends
2.3.2 Immunotherapy Market Drivers
2.3.3 Immunotherapy Market Challenges
2.3.4 Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunotherapy Players by Revenue
3.1.1 Global Top Immunotherapy Players by Revenue (2019-2024)
3.1.2 Global Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunotherapy Revenue
3.4 Global Immunotherapy Market Concentration Ratio
3.4.1 Global Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Revenue in 2023
3.5 Immunotherapy Key Players Head office and Area Served
3.6 Key Players Immunotherapy Product Solution and Service
3.7 Date of Enter into Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapy Breakdown Data by Type
4.1 Global Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global Immunotherapy Forecasted Market Size by Type (2025-2030)
5 Immunotherapy Breakdown Data by Application
5.1 Global Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immunotherapy Market Size (2019-2030)
6.2 North America Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immunotherapy Market Size by Country (2019-2024)
6.4 North America Immunotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunotherapy Market Size (2019-2030)
7.2 Europe Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immunotherapy Market Size by Country (2019-2024)
7.4 Europe Immunotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunotherapy Market Size (2019-2030)
8.2 Asia-Pacific Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immunotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Immunotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunotherapy Market Size (2019-2030)
9.2 Latin America Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immunotherapy Market Size by Country (2019-2024)
9.4 Latin America Immunotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunotherapy Market Size (2019-2030)
10.2 Middle East & Africa Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immunotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Immunotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Immunotherapy Introduction
11.1.4 Abbvie Revenue in Immunotherapy Business (2019-2024)
11.1.5 Abbvie Recent Development
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Company Detail
11.2.2 Amgen, Inc. Business Overview
11.2.3 Amgen, Inc. Immunotherapy Introduction
11.2.4 Amgen, Inc. Revenue in Immunotherapy Business (2019-2024)
11.2.5 Amgen, Inc. Recent Development
11.3 Biogen
11.3.1 Biogen Company Detail
11.3.2 Biogen Business Overview
11.3.3 Biogen Immunotherapy Introduction
11.3.4 Biogen Revenue in Immunotherapy Business (2019-2024)
11.3.5 Biogen Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Immunotherapy Introduction
11.4.4 Bristol-Myers Squibb Revenue in Immunotherapy Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Immunotherapy Introduction
11.5.4 Celgene Revenue in Immunotherapy Business (2019-2024)
11.5.5 Celgene Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Immunotherapy Introduction
11.6.4 Johnson & Johnson Revenue in Immunotherapy Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Immunotherapy Introduction
11.7.4 Merck Revenue in Immunotherapy Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Immunotherapy Introduction
11.8.4 Novartis Revenue in Immunotherapy Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Immunotherapy Introduction
11.9.4 Pfizer Revenue in Immunotherapy Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Immunotherapy Introduction
11.10.4 Roche Revenue in Immunotherapy Business (2019-2024)
11.10.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
